カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のドロスピレノン及びエチニルエストラジオール錠剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Drospirenone and Ethinyl Estradiol Tablets Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19274）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19274
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のドロスピレノン及びエチニルエストラジオール錠剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ドロスピレノン及びエチニルエストラジオール錠剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のドロスピレノン及びエチニルエストラジオール錠剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ドロスピレノン及びエチニルエストラジオール錠剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・3mg/0.03mg、3mg/0.02mg

用途別セグメントは次のように区分されます。
・薬局、病院、クリニック、オンラインストア

世界のドロスピレノン及びエチニルエストラジオール錠剤市場の主要な市場プレーヤーは以下のとおりです。
・Bayer AG、Camber Pharmaceuticals、Morningside Pharmaceuticals、Lupin Pharmaceuticals、Xiromed、Sun Pharmaceutical、Hetero Drugs、Jubilant Cadista、Mylan、Glenmark Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ドロスピレノン及びエチニルエストラジオール錠剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なドロスピレノン及びエチニルエストラジオール錠剤メーカーの企業概要、2019年～2022年までのドロスピレノン及びエチニルエストラジオール錠剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なドロスピレノン及びエチニルエストラジオール錠剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ドロスピレノン及びエチニルエストラジオール錠剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのドロスピレノン及びエチニルエストラジオール錠剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのドロスピレノン及びエチニルエストラジオール錠剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびドロスピレノン及びエチニルエストラジオール錠剤の産業チェーンを掲載しています。
・第13、14、15章では、ドロスピレノン及びエチニルエストラジオール錠剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ドロスピレノン及びエチニルエストラジオール錠剤の概要
- 種類別分析（2017年vs2021年vs2028年）：3mg/0.03mg、3mg/0.02mg
- 用途別分析（2017年vs2021年vs2028年）：薬局、病院、クリニック、オンラインストア
- 世界のドロスピレノン及びエチニルエストラジオール錠剤市場規模・予測
- 世界のドロスピレノン及びエチニルエストラジオール錠剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bayer AG、Camber Pharmaceuticals、Morningside Pharmaceuticals、Lupin Pharmaceuticals、Xiromed、Sun Pharmaceutical、Hetero Drugs、Jubilant Cadista、Mylan、Glenmark Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：3mg/0.03mg、3mg/0.02mg
・用途別分析2017年-2028年：薬局、病院、クリニック、オンラインストア
・ドロスピレノン及びエチニルエストラジオール錠剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ドロスピレノン及びエチニルエストラジオール錠剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ドロスピレノン及びエチニルエストラジオール錠剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ドロスピレノン及びエチニルエストラジオール錠剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ドロスピレノン及びエチニルエストラジオール錠剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Drospirenone and Ethinyl Estradiol Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drospirenone and Ethinyl Estradiol Tablets market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmacy accounting for % of the Drospirenone and Ethinyl Estradiol Tablets global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 3mg/0.03mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drospirenone and Ethinyl Estradiol Tablets include Bayer AG, Camber Pharmaceuticals, Morningside Pharmaceuticals, Lupin Pharmaceuticals, and Xiromed, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drospirenone and Ethinyl Estradiol Tablets market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
3mg/0.03mg
3mg/0.02mg
Market segment by Application can be divided into
Pharmacy
Hospital
Clinic
Online Store
The key market players for global Drospirenone and Ethinyl Estradiol Tablets market are listed below:
Bayer AG
Camber Pharmaceuticals
Morningside Pharmaceuticals
Lupin Pharmaceuticals
Xiromed
Sun Pharmaceutical
Hetero Drugs
Jubilant Cadista
Mylan
Glenmark Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drospirenone and Ethinyl Estradiol Tablets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drospirenone and Ethinyl Estradiol Tablets, with price, sales, revenue and global market share of Drospirenone and Ethinyl Estradiol Tablets from 2019 to 2022.
Chapter 3, the Drospirenone and Ethinyl Estradiol Tablets competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drospirenone and Ethinyl Estradiol Tablets breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drospirenone and Ethinyl Estradiol Tablets market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drospirenone and Ethinyl Estradiol Tablets.
Chapter 13, 14, and 15, to describe Drospirenone and Ethinyl Estradiol Tablets sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Drospirenone and Ethinyl Estradiol Tablets Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 3mg/0.03mg
1.2.3 3mg/0.02mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Online Store
1.4 Global Drospirenone and Ethinyl Estradiol Tablets Market Size & Forecast
1.4.1 Global Drospirenone and Ethinyl Estradiol Tablets Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drospirenone and Ethinyl Estradiol Tablets Sales in Volume (2017-2028)
1.4.3 Global Drospirenone and Ethinyl Estradiol Tablets Price (2017-2028)
1.5 Global Drospirenone and Ethinyl Estradiol Tablets Production Capacity Analysis
1.5.1 Global Drospirenone and Ethinyl Estradiol Tablets Total Production Capacity (2017-2028)
1.5.2 Global Drospirenone and Ethinyl Estradiol Tablets Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drospirenone and Ethinyl Estradiol Tablets Market Drivers
1.6.2 Drospirenone and Ethinyl Estradiol Tablets Market Restraints
1.6.3 Drospirenone and Ethinyl Estradiol Tablets Trends Analysis
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.1.4 Bayer AG Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Camber Pharmaceuticals
2.2.1 Camber Pharmaceuticals Details
2.2.2 Camber Pharmaceuticals Major Business
2.2.3 Camber Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.2.4 Camber Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Morningside Pharmaceuticals
2.3.1 Morningside Pharmaceuticals Details
2.3.2 Morningside Pharmaceuticals Major Business
2.3.3 Morningside Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.3.4 Morningside Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lupin Pharmaceuticals
2.4.1 Lupin Pharmaceuticals Details
2.4.2 Lupin Pharmaceuticals Major Business
2.4.3 Lupin Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.4.4 Lupin Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Xiromed
2.5.1 Xiromed Details
2.5.2 Xiromed Major Business
2.5.3 Xiromed Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.5.4 Xiromed Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sun Pharmaceutical
2.6.1 Sun Pharmaceutical Details
2.6.2 Sun Pharmaceutical Major Business
2.6.3 Sun Pharmaceutical Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.6.4 Sun Pharmaceutical Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hetero Drugs
2.7.1 Hetero Drugs Details
2.7.2 Hetero Drugs Major Business
2.7.3 Hetero Drugs Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.7.4 Hetero Drugs Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Jubilant Cadista
2.8.1 Jubilant Cadista Details
2.8.2 Jubilant Cadista Major Business
2.8.3 Jubilant Cadista Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.8.4 Jubilant Cadista Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.9.4 Mylan Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Glenmark Pharmaceuticals
2.10.1 Glenmark Pharmaceuticals Details
2.10.2 Glenmark Pharmaceuticals Major Business
2.10.3 Glenmark Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
2.10.4 Glenmark Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drospirenone and Ethinyl Estradiol Tablets Breakdown Data by Manufacturer
3.1 Global Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drospirenone and Ethinyl Estradiol Tablets
3.4 Market Concentration Rate
3.4.1 Top 3 Drospirenone and Ethinyl Estradiol Tablets Manufacturer Market Share in 2021
3.4.2 Top 6 Drospirenone and Ethinyl Estradiol Tablets Manufacturer Market Share in 2021
3.5 Global Drospirenone and Ethinyl Estradiol Tablets Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drospirenone and Ethinyl Estradiol Tablets Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drospirenone and Ethinyl Estradiol Tablets Market Size by Region
4.1.1 Global Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Region (2017-2028)
4.1.2 Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2017-2028)
4.2 North America Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028)
4.3 Europe Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028)
4.4 Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028)
4.5 South America Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028)
4.6 Middle East and Africa Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Type (2017-2028)
5.2 Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Type (2017-2028)
5.3 Global Drospirenone and Ethinyl Estradiol Tablets Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Application (2017-2028)
6.2 Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Application (2017-2028)
6.3 Global Drospirenone and Ethinyl Estradiol Tablets Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2028)
7.2 North America Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2028)
7.3 North America Drospirenone and Ethinyl Estradiol Tablets Market Size by Country
7.3.1 North America Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Country (2017-2028)
7.3.2 North America Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2028)
8.2 Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2028)
8.3 Europe Drospirenone and Ethinyl Estradiol Tablets Market Size by Country
8.3.1 Europe Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Country (2017-2028)
8.3.2 Europe Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2028)
9.2 Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2028)
9.3 Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Market Size by Region
9.3.1 Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2028)
10.2 South America Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2028)
10.3 South America Drospirenone and Ethinyl Estradiol Tablets Market Size by Country
10.3.1 South America Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Country (2017-2028)
10.3.2 South America Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2028)
11.2 Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2028)
11.3 Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Market Size by Country
11.3.1 Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drospirenone and Ethinyl Estradiol Tablets and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drospirenone and Ethinyl Estradiol Tablets
12.3 Drospirenone and Ethinyl Estradiol Tablets Production Process
12.4 Drospirenone and Ethinyl Estradiol Tablets Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drospirenone and Ethinyl Estradiol Tablets Typical Distributors
13.3 Drospirenone and Ethinyl Estradiol Tablets Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 6. Bayer AG Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Camber Pharmaceuticals Major Business
Table 9. Camber Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 10. Camber Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Morningside Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Morningside Pharmaceuticals Major Business
Table 13. Morningside Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 14. Morningside Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Lupin Pharmaceuticals Major Business
Table 17. Lupin Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 18. Lupin Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Xiromed Basic Information, Manufacturing Base and Competitors
Table 20. Xiromed Major Business
Table 21. Xiromed Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 22. Xiromed Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Major Business
Table 25. Sun Pharmaceutical Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 26. Sun Pharmaceutical Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 28. Hetero Drugs Major Business
Table 29. Hetero Drugs Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 30. Hetero Drugs Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Jubilant Cadista Basic Information, Manufacturing Base and Competitors
Table 32. Jubilant Cadista Major Business
Table 33. Jubilant Cadista Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 34. Jubilant Cadista Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Major Business
Table 37. Mylan Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 38. Mylan Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Glenmark Pharmaceuticals Major Business
Table 41. Glenmark Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Product and Services
Table 42. Glenmark Pharmaceuticals Drospirenone and Ethinyl Estradiol Tablets Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drospirenone and Ethinyl Estradiol Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drospirenone and Ethinyl Estradiol Tablets Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drospirenone and Ethinyl Estradiol Tablets Production Site of Key Manufacturer
Table 48. Drospirenone and Ethinyl Estradiol Tablets New Entrant and Capacity Expansion Plans
Table 49. Drospirenone and Ethinyl Estradiol Tablets Mergers & Acquisitions in the Past Five Years
Table 50. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Region (2017-2022) & (K Units)
Table 51. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Region (2023-2028) & (K Units)
Table 52. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 55. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 56. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drospirenone and Ethinyl Estradiol Tablets Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Drospirenone and Ethinyl Estradiol Tablets Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 61. Global Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 62. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drospirenone and Ethinyl Estradiol Tablets Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drospirenone and Ethinyl Estradiol Tablets Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Drospirenone and Ethinyl Estradiol Tablets Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Drospirenone and Ethinyl Estradiol Tablets Sales by Country (2017-2022) & (K Units)
Table 67. North America Drospirenone and Ethinyl Estradiol Tablets Sales by Country (2023-2028) & (K Units)
Table 68. North America Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 71. North America Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 72. North America Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 73. North America Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 90. South America Drospirenone and Ethinyl Estradiol Tablets Sales by Country (2017-2022) & (K Units)
Table 91. South America Drospirenone and Ethinyl Estradiol Tablets Sales by Country (2023-2028) & (K Units)
Table 92. South America Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drospirenone and Ethinyl Estradiol Tablets Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 95. South America Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 96. South America Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 97. South America Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales by Application (2023-2028) & (K Units)
Table 106. Drospirenone and Ethinyl Estradiol Tablets Raw Material
Table 107. Key Manufacturers of Drospirenone and Ethinyl Estradiol Tablets Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drospirenone and Ethinyl Estradiol Tablets Typical Distributors
Table 111. Drospirenone and Ethinyl Estradiol Tablets Typical Customers
List of Figures
Figure 1. Drospirenone and Ethinyl Estradiol Tablets Picture
Figure 2. Global Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Type in 2021
Figure 3. 3mg/0.03mg
Figure 4. 3mg/0.02mg
Figure 5. Global Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Application in 2021
Figure 6. Pharmacy
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Online Store
Figure 10. Global Drospirenone and Ethinyl Estradiol Tablets Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Drospirenone and Ethinyl Estradiol Tablets Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Drospirenone and Ethinyl Estradiol Tablets Sales (2017-2028) & (K Units)
Figure 13. Global Drospirenone and Ethinyl Estradiol Tablets Price (2017-2028) & (US$/Unit)
Figure 14. Global Drospirenone and Ethinyl Estradiol Tablets Production Capacity (2017-2028) & (K Units)
Figure 15. Global Drospirenone and Ethinyl Estradiol Tablets Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Drospirenone and Ethinyl Estradiol Tablets Market Drivers
Figure 17. Drospirenone and Ethinyl Estradiol Tablets Market Restraints
Figure 18. Drospirenone and Ethinyl Estradiol Tablets Market Trends
Figure 19. Global Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Manufacturer in 2021
Figure 20. Global Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Manufacturer in 2021
Figure 21. Drospirenone and Ethinyl Estradiol Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Drospirenone and Ethinyl Estradiol Tablets Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Drospirenone and Ethinyl Estradiol Tablets Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Region (2017-2028)
Figure 25. Global Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Region (2017-2028)
Figure 26. North America Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 27. Europe Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 29. South America Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Revenue (2017-2028) & (USD Million)
Figure 31. Global Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Type (2017-2028)
Figure 32. Global Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Type (2017-2028)
Figure 33. Global Drospirenone and Ethinyl Estradiol Tablets Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Application (2017-2028)
Figure 35. Global Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Application (2017-2028)
Figure 36. Global Drospirenone and Ethinyl Estradiol Tablets Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Type (2017-2028)
Figure 38. North America Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Application (2017-2028)
Figure 39. North America Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Country (2017-2028)
Figure 40. North America Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Country (2017-2028)
Figure 41. United States Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Type (2017-2028)
Figure 45. Europe Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Application (2017-2028)
Figure 46. Europe Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Country (2017-2028)
Figure 47. Europe Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Country (2017-2028)
Figure 48. Germany Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Region (2017-2028)
Figure 57. China Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Type (2017-2028)
Figure 64. South America Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Application (2017-2028)
Figure 65. South America Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Country (2017-2028)
Figure 66. South America Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Drospirenone and Ethinyl Estradiol Tablets Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Drospirenone and Ethinyl Estradiol Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Drospirenone and Ethinyl Estradiol Tablets in 2021
Figure 78. Manufacturing Process Analysis of Drospirenone and Ethinyl Estradiol Tablets
Figure 79. Drospirenone and Ethinyl Estradiol Tablets Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • エストラジオールELISA検査キットのグローバル市場展望 2023年-2029年：診断用エストラジオールELISA検査キット、研究用エストラジオールELISA検査キット
  • 世界のエルトロンボパグ錠市場2022年：市場規模予測（～2028年）
  • 世界のラロキシフェン塩酸塩錠市場2022年：市場規模予測（～2028年）
  • チオプロニン錠剤のグローバル市場展望 2023年-2029年：100mg、300mg
  • ゾルピデム酒石酸塩錠のグローバル市場展望 2023年-2029年：5mg、10mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19274 )"世界のドロスピレノン及びエチニルエストラジオール錠剤市場2022年：市場規模予測（～2028年）" (英文：Global Drospirenone and Ethinyl Estradiol Tablets Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。